CAPRICOR THERAPEUTICS, INC. Common Stock, Value, Issued
CAPRICOR THERAPEUTICS, INC. (CAPR) had Common Stock, Value, Issued of $58.11 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-14
- 2026-06-30: Common Stock, Value, Issued $58.11K.
- 2026-03-31: Common Stock, Value, Issued $57.66K.
- 2025-12-31: Common Stock, Value, Issued $57.37K.
- 2025-09-30: Common Stock, Value, Issued $45.72K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $58.11K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $57.66K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $57.37K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $45.72K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $45.71K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $45.68K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $45.58K 10-K · filed 2026-03-17 | |
| 2024-09-30 | $40.33K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $31.98K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $31.60K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $31.15K 10-K · filed 2025-03-26 | |
| 2023-09-30 | $25.86K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $25.76K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $25.25K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $25.24K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $24.70K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $24.34K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $24.32K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $24.18K 10-K · filed 2023-03-17 | |
| 2021-09-30 | $24.15K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $23.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $22.80K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $20.58K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $20.21K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $19.70K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $9.19K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $5.23K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $4.17K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $3.47K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $33.66K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $3.14K 10-K · filed 2020-03-27 | $31.39K 10-K · filed 2019-03-29 |
| 2018-09-30 | $30.75K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $29.99K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $27.97K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $26.27K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $25.10K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $22.59K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $21.40K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $21.40K 10-K · filed 2018-03-22 | |
| 2016-09-30 | $21.40K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $17.95K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $17.95K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $16.25K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $16.25K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $16.22K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $16.22K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $11.71K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $11.70K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $11.70K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $11.69K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $11.69K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $43.52K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $43.06K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $43.06K 10-Q · filed 2013-06-21 | |
| 2012-12-31 | $10.35K 10-K · filed 2014-03-31 | $43.06K 10-K · filed 2013-06-21 |
| 2012-09-30 | $43.06K 10-Q · filed 2013-06-21 | |
| 2012-06-30 | $43.06K 10-Q/A · filed 2012-09-10 | |
| 2012-03-31 | $39.71K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $39.71K 10-Q · filed 2013-06-21 | |
| 2011-09-30 | $39.71K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $39.71K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $34.63K 10-K · filed 2012-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |